VEBANVIBART
UNII 5TL7E5D6E6

Substance Identification & Data

This profile provides standardized clinical and technical data for Vebanvibart, uniquely identified by the FDA Unique Ingredient Identifier (UNII) 5TL7E5D6E6.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 2937321-40-7 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

5TL7E5D6E6

CAS Registry Number

2937321-40-7

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

VEBANVIBART

Official standardized name for this substance within the FDA UNII nomenclature system.

NCI Thesaurus

C207010

National Cancer Institute reference terminology for clinical and research data.

INN ID

13272

Sequential identifier assigned via the WHO International Nonproprietary Name program.

Substance Type

protein

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Vebanvibart. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

VEBANVIBART

Common Names & Synonyms

H-GAMMA1 HEAVY CHAIN HOMO SAPIENS (1-455) (VH (HOMO SAPIENS IGHV1-69*01 (88.8%) -(IGHD) -IGHJ4*01 (85.7%) S128>A (125), CDR-IMGT (8.8.18) (26-33.51-58.97-114)) (1-125) -HOMO SAPIENS IGHG1*01, G1M17,1, CH1 K120, CH3 D12, L14, G1V21 CH2 Y15.1, T16, E18 (CH1 K120 (222) (126-223), HINGE 1-15 (224-238), CH2 M15.1>Y (260), S16>T (262), T18>E (264) (239-348), CH3 D12 (364), L14 (366) (349-453), CHS (454-455)) (126-455)), (228-215')-DISULFIDE WITH L-KAPPA LIGHT CHAIN HOMO SAPIENS (1'-215') (VKAPPA (HOMO SAPIENS IGKV1-33*01 (95.8%) -IGKJ2*01 (91.7%), CDR-IMGT (6.3.10) (27'-32'.50'-52'.89'-98')) (1'-108') -HOMO SAPIENS IGKC*01 (100%), KM3 A45.1 (154'), V101 (192') (109'-215')); DIMER (234-234'':237-237'')-BISDISULFIDE, PRODUCED IN A CELL LINE FROM CHINESE HAMSTER OVARY (CHO) CELLS, DERIVED FROM THE CELL LINE CHO-K1, GLYCOFORM ALFA

IMMUNOGLOBULIN G1 (260-TYROSINE,262-THREONINE,264-GLUTAMIC ACID), ANTI-(SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2 SPIKE GLYCOPROTEIN RECEPTOR-BINDING DOMAIN) (HUMAN MONOCLONAL SA55 .GAMMA.1-CHAIN), DISULFIDE WITH HUMAN MONOCLONAL SA55 .KAPPA.-CHAIN, DIMER

IMMUNOGLOBULIN G1-KAPPA, ANTI-(SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2 (SARS-COV-2) SPIKE (S) PROTEIN, RECEPTOR BINDING DOMAIN (RBD)), HOMO SAPIENS MONOCLONAL ANTIBODY (VEBANVIBART)

VEBANVIBART [INN]